News

Orkambi, a combination drug for cystic fibrosis, has been found to improve the lung function of children suffering from the disease.

Royal Brompton & Harefield NHS Foundation Trust  has been awarded special funding from the Cystic Fibrosis Trust to scale up its clinical trials for the disease, which help to pioneer new treatments for patients across the country.

Campaigners fighting the closure of the Trust’s congenital heart disease (CHD) services today launch a new film to encourage people to respond to NHS England’s public consultation.

12 year-old Sadia Begum has become the first Royal Brompton patient to receive a diagnosis of her rare condition, Primary Ciliary Dyskinesia or PCD, via the 100,000 Genomes Project.